Multiple chemical sensitivity syndrome is an acquired condition that occurs when a person who is exposed to substances or chemical compounds at levels common in our environment and not normally deemed to be harmful, experiences a range of symptoms following contact. Examples of some chemical compounds can include:
- exhaust fumes
- perfumes
- new building products
- chemical fumes
- pesticides
- household cleaning products and deodorizers
- tobacco smoke
- food additives, colours and preservatives
- foods.
Symptoms and characteristics:
People with multiple chemical sensitivity syndrome react to varying compounds and experience different symptoms. People may be exposed to chemical irritants through inhalation, ingestion or direct contact. Resulting symptoms commonly reported by people with multiple chemical sensitivity syndrome following exposure can include:
- headaches and nausea
- difficulty concentrating and confusion
- impaired memory
- changes in mood and irritability
- watery eyes
- throat or nasal irritation
- muscle and joint pains
- skin irritation including rashes
- changes in bowel habits
- respiratory difficulties
- dizziness
- fatigue.
Reactions to specific chemical exposure can last between hours to weeks.
Workplace solutions and adjustments:
People with multiple chemical sensitivity syndrome usually control symptoms by limiting exposure to the suspected cause. As a result, changes may need to be considered in the workplace to limit a person's exposure to the problem substance or substances.
As chemical compounds can be associated with new clothing, building products, chemicals used within the workplace and even fumes associated with driving to and from work, each case needs to be considered uniquely. The use of protective gloves and clothing to minimise skin contact with compounds and respiratory masks to reduce inhalation of compounds may be of some assistance.
There are solutions and adjustments for the following job requirements:
References:
MDGuidelines 1991-2010, Multiple Chemical Sensitivity Syndrome, Reed Group, Colorado, viewed 14 February 2012, http://www.mdguidelines.com.